Macrophage and Retinal Pigment Epithelium Phagocytosis: Apoptotic Cells and Photoreceptors Compete for αvβ3 and αvβ5 Integrins, and Protein Kinase C Regulates αvβ5 Binding and Cytoskeletal Linkage by Finnemann, Silvia C. & Rodriguez-Boulan, Enrique
 
861
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/99/09/861/14 $5.00
Volume 190, Number 6, September 20, 1999 861–874
http://www.jem.org
 
Macrophage and Retinal Pigment Epithelium Phagocytosis: 
Apoptotic Cells and Photoreceptors Compete for 
 
a
 
v
 
b
 
3 and 
 
a
 
v
 
b
 
5 Integrins, and Protein Kinase C Regulates 
 
a
 
v
 
b
 
5 
Binding and Cytoskeletal Linkage
 
By Silvia C. Finnemann and Enrique Rodriguez-Boulan
 
From the Department of Ophthalmology and Department of Cell Biology, Margaret M. Dyson Vision 
Institute, Weill Medical College of Cornell University, New York, New York 10021
 
Summary
 
Noninflammatory monocyte macrophages use 
 
a
 
v
 
b
 
3 integrin to selectively bind apoptotic cells,
initiating their phagocytic removal. In a related process, the retinal pigment epithelium (RPE)
employs 
 
a
 
v
 
b
 
5 integrin to recognize spent photoreceptor outer segment particles (OS). Here,
we show that apoptotic cells and OS compete for binding to these receptors, indicating that
OS and apoptotic cells expose surface signals recognizable by 
 
a
 
v
 
b
 
3 and 
 
a
 
v
 
b
 
5. Particle binding
to 
 
a
 
v
 
b
 
5 required protein kinase C (PKC) activation. In RPE, 
 
a
 
v
 
b
 
5 binding was maximally
activated even before any phagocytic challenge and was reduced by PKC inhibitors. In mac-
rophages, it was dormant but became activated upon PKC stimulation. PKC-activated 
 
a
 
v
 
b
 
5-
mediated binding in macrophages differed from constitutive binding to the same integrin re-
ceptor in RPE cells in that the former followed much faster kinetics, similar to particle binding
mediated by 
 
a
 
v
 
b
 
3. Activation of 
 
a
 
v
 
b
 
5 for particle binding correlated with its recruitment into
a detergent-insoluble fraction, a process sensitive to pharmacological modulation of PKC in
both types of phagocytes. Furthermore, 
 
a
 
v
 
b
 
5 but not 
 
a
 
v
 
b
 
3 particle binding required actin mi-
crofilaments. These data constitute the first evidence that noninflammatory phagocytes actively
regulate the earliest phase of phagocytic clearance, particle binding, by controlling receptor ac-
tivity.
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C
 
learance phagocytosis of apoptotic cells and debris
plays a critical role in remodeling and maintenance
of tissues. Noninflammatory phagocytosis prevents tissue
damage that would result from leakage of cytoplasmic
components (1, 2). Typical examples of this macrophage
activity are the efficient removal of large numbers of apop-
totic cells during embryonic development (3) or of acti-
vated granulocytes undergoing programmed cell death at
the end of an immune response (4). The binding and
phagocytosis phases of apoptotic cell removal each involve
specific receptors in the macrophage, such as the li-
popolysaccharide receptor CD14 (5), phosphatidylserine
receptors (6), the integrin receptor 
 
a
 
v
 
b
 
3 (7), and the scav-
enger receptors SRA1 and CD36 (8, 9). Binding receptors
recognize phosphatidylserine, oxidized lipids, and other
unidentified phagocytic signals exposed by apoptotic cells
(10, 11). The available data suggest that different recogni-
tion receptors initiating phagocytosis of apoptotic cells may
be used independently, depending on the activation state of
the macrophage population (12, 13). This is especially well
established for the availability of 
 
a
 
v
 
b
 
3 integrin for apop-
totic cell binding. 
 
a
 
v
 
b
 
3 does not participate in particle
binding by macrophages that were previously stimulated by
thioglycollate, activated by cytokines, or phagocytically
challenged (12, 14). In contrast, 
 
a
 
v
 
b
 
3 is an important
binding receptor in noninflammatory bone marrow– or
monocyte-derived macrophages, as 
 
a
 
v
 
b
 
3 function-block-
ing antibodies or peptides containing the cognate integrin
ligand motif Arg-Gly-Asp drastically reduce particle attach-
ment (7, 12). Monocyte-derived macrophages use either
 
a
 
v
 
b
 
3 integrin or leukocyte-specific integrin receptors
 
a
 
M
 
b
 
2 (CD11b/CD18, CR3) and 
 
a
 
X
 
b
 
2 (CD11c/CD18,
CR4), presumably in parallel, to bind apoptotic cells,
which have been opsonized with complement components
(15). The mechanisms used by macrophages to activate or
deactivate specific binding receptors for apoptotic cells are
entirely unknown.
Noninflammatory receptor–mediated clearance of cell 
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Phagocyte Regulation of Integrin 
 
a
 
v
 
b
 
5 for Apoptotic Cell Binding
 
debris is also efficiently carried out by a specialized tissue in
the retina, the retinal pigment epithelium (RPE).
 
1
 
 RPE
cells phagocytose huge loads of material shed by the adja-
cent photoreceptor layer (
 
z
 
7% of their outer segment
mass, daily) as part of a circadian renewal program that
compensates the damaging effects of light (16, 17). RPE
phagocytosis of shed outer segment particles (OS) is key for
the integrity of the eye, as its failure leads to retinal degen-
eration (18, 19). RPE cells highly prefer OS over bacteria,
yeast, and opsonized red blood cells, even when they may
express a population of Fc receptors (20). CD36 is ex-
pressed by the RPE and participates in the internalization
phase of OS clearance (21). Indirect evidence suggests that
a mannose receptor–like activity also plays a role in RPE
internalization of OS (22). However, the RPE mannose
receptor sequence has not yet been cloned, and its exact
role in OS phagocytosis is unclear. Although only some
soluble mannose receptor ligands affect OS phagocytosis
(23, 24), yeast and zymosan particles, which are recognized
by macrophages via the mannose receptor, do not compete
with OS for binding or internalization by RPE cells (20,
and our unpublished results).
OS binding by RPE cells and apoptotic cell binding by
macrophages use the related integrin receptors 
 
a
 
v
 
b
 
5 and
 
a
 
v
 
b
 
3, respectively (25, 26). However, the binding phases
of the two processes show some important differences: (a)
RPE cells bind OS slowly (over 
 
z
 
2 h) only after a lag
phase (20, 26), whereas macrophages bind particles maxi-
mally in 30 min. (b) RPE cells bind OS only at tempera-
tures 
 
.
 
17
 
8
 
C (27), whereas a temperature requirement of
macrophage binding of apoptotic cells, to our knowledge,
has not been reported. However, macrophage binding of
particles via Fc receptors or complement receptor 
 
b
 
2 inte-
grins is normal at 0
 
8
 
C (28). (c) RPE cells primarily use
 
a
 
v
 
b
 
5 (25, 26) for particle binding (
 
a
 
v
 
b
 
5 antibodies reduce
binding by 85%), whereas macrophages may use 
 
a
 
v
 
b
 
3 and
other receptors, in parallel (
 
a
 
v
 
b
 
3 antibodies reduce binding
by 
 
z
 
50%). Very recent work has shown that phagocytosis
of apoptotic cells by immature human blood–derived
dendritic cells can be reduced to a similar extent by 
 
a
 
v
 
b
 
5
integrin–inhibiting antibodies; upon cytokine-induced mat-
uration, the phagocytic activity of these cells decreases co-
incident with downregulation of 
 
b
 
5 (29).
The experiments in this report characterize the role of
 
a
 
v
 
b
 
3 and 
 
a
 
v
 
b
 
5 integrin receptors in the initial binding
phase of monocyte macrophage and RPE phagocytosis of
apoptotic cells and OS. We first tested the hypothesis that
the specific particle ligand (OS versus apoptotic cell) could
determine the use of a particular integrin, 
 
a
 
v
 
b
 
5 by RPE
and 
 
a
 
v
 
b
 
3 by macrophages. The experiments led us to dis-
card this hypothesis as both cell types recognized apoptotic
cells and OS efficiently and competitively, employing the
same binding integrins they use for their respective physio-
logic ligands. As both phagocyte types expressed 
 
a
 
v
 
b
 
3 and
 
a
 
v
 
b
 
5, we tested the hypothesis that the activation of a par-
ticular integrin pathway by each cell type could be regu-
lated by specific signaling pathways. Indeed, this was ob-
served: our experiments revealed a critical role for PKC in
activating 
 
a
 
v
 
b
 
5 for particle binding. Activation of dormant
 
a
 
v
 
b
 
5 receptors in macrophages did not alter cell-specific
differences in particle binding, as these receptors bound
apoptotic cells or OS with fast kinetics distinct from the
characteristic slow onset of binding initiating RPE phago-
cytosis. Both 
 
a
 
v
 
b
 
5 and 
 
a
 
v
 
b
 
3 integrins required tempera-
tures of at least 18
 
8
 
C for particle binding, in contrast to 
 
b
 
2
integrins or Fc receptors. Remarkably, 
 
a
 
v
 
b
 
5 receptors
themselves became resistant to detergent extraction upon
PKC activation. Since intact actin microfilaments were re-
quired for 
 
a
 
v
 
b
 
5-mediated particle binding, interaction
with the actin cytoskeleton appears to be an important fea-
ture of 
 
a
 
v
 
b
 
5 receptor activation.
 
Materials and Methods
 
Materials.
 
Reagents were from Sigma Chemical Co. or
GIBCO BRL unless otherwise stated. Pharmacological reagents
were obtained from Biomol or Sigma Chemical Co., stored as
1,000
 
3
 
 stock solutions in DMSO at 
 
2
 
20
 
8
 
C, and diluted into cell
culture medium directly before use. The following antibodies
were used: rat 
 
a
 
v
 
b
 
3 function-blocking 
 
b
 
3 antibody clone F11
(30, 31) and mouse 
 
b3 function-blocking antibody clone
2C9.G2 (32) were from PharMingen. Immunoprecipitating,
function-blocking, heterodimer-selective avb5 antibody clone
P1F6 (33) was from Chemicon. P1F6 recognizes avb5 in many
species, including rodents (26, 33; and this study, see Fig. 8). For
immunoblot detection, b5 antibodies were purchased from
Chemicon or from Upstate Biotechnology (clone B5-IVF2 [34]),
and b3 antibody clone 26 was from Transduction Laboratories.
Myeloperoxidase antiserum was from Dako. Mouse aM func-
tion-blocking antibody 5C6 (35) was a gift from Dr. W.A.
Muller (Weill Medical College of Cornell University). Secondary
antibodies were from Jackson ImmunoResearch Laboratories.
Terminal deoxynucleotidyl transferase–mediated dUTP nick
end labeling (TUNEL) detection was performed using the Fluo-
rescein In Situ Cell Death detection kit from Boehringer Mann-
heim. Surface phosphatidylserine was detected using the Apo-
Alert Cell Death detection kit from Clontech.
Cell Culture. J774.A1 murine macrophages, NRK-F49 rat fi-
broblasts, and rat RPE-J cells were obtained from American Type
Culture Collection and routinely maintained in DMEM supple-
mented with 10 or 4% (RPE) FCS. For binding and phagocytosis
experiments, macrophages and fibroblasts were seeded at conflu-
ence on glass coverslips for 30 min or overnight before use.
RPE-J cells were differentiated on semipermeable filters as de-
scribed previously (36). Rat primary cells were isolated from
adult Long Evans rats (Richard Harlan, Inc.) immediately after
CO2 asphyxiation. Rat bone marrow–derived macrophages and
rat blood–derived monocyte macrophages were prepared and
maintained according to published procedures (13, 37). In brief,
blood-derived monocytes were isolated by plastic adherence after
Ficoll gradient purification of leukocytes from anticoagulant-
treated rat blood. Bone marrow cells were flushed aseptically
from femur bones of Long Evans rats, washed, seeded, and used
without repassaging. All primary macrophages were cultured for
1Abbreviations used in this paper: Cyt D, cytochalasin D; OS, outer segment
particle(s); PKC, protein kinase C; RPE, retinal pigment epithelium;
TUNEL, terminal deoxynucleotidyl transferase–mediated dUTP nick
end labeling.863 Finnemann and Rodriguez-Boulan
6–7 d before use in IMDM, supplemented with 10% autologous
serum; bone marrow–derived cell medium was supplemented
with 5% L cell–conditioned medium (Sigma Chemical Co.) as a
source of M-CSF (13). Primary rat neutrophils, which were iso-
lated from fresh rat blood according to established protocols (38),
underwent spontaneous apoptosis over 24 h in culture. HL-60
cells, a gift from Dr. F. Maxfield (Weill Medical College of Cor-
nell University) were maintained in 10% FCS in RPMI. To in-
duce differentiation and apoptosis, HL-60 cells were cultured in
the dark at 2 3 105 cells/ml in growth medium containing 1 mM
all-trans retinoic acid for 6 d. Before binding or phagocytosis as-
says, apoptotic cells were routinely tested for viability by trypan
blue exclusion and phosphatidylserine surface exposure staining
with FITC–annexin V. All populations used were .95% viable
and .60% annexin V positive.
Preparation of Photoreceptor OS. OS were isolated according to
established protocols from bovine eyes obtained fresh from the
slaughterhouse (39). OS were stored suspended in 10 mM so-
dium phosphate, pH 7.2, 0.1 M sodium chloride, 2.5% sucrose at
2808C. Before use, OS were thawed and labeled by addition of
20% vol of 1 mg/ml FITC or 0.2 mg/ml Texas red (both from
Molecular Probes) in 0.1 M sodium bicarbonate, pH 9.0, for 1 h
at room temperature in the dark, before being washed and resus-
pended in cell culture medium.
Opsonization of Zymosan. Zymosan particles were opsonized
with serum complement components as described previously
(40). In brief, 1% zymosan particles in PBS were boiled for 30
min and opsonized in 50% bovine serum in HBSS for 1 h at
378C. Washed particles were labeled with FITC as described for
OS, and stored at 48C.
Particle Binding and Phagocytosis Experiments. To study particle
binding, phagocytes at confluence were challenged with 10 parti-
cles per cell in growth medium (RPE) or serum-free growth me-
dium (other cells) for the duration of the experiment, washed
three times with PBS containing 1 mM MgCl2 and 0.2 mM
CaCl2 (PBS-CM), and fixed in ice-cold methanol. OS were co-
valently labeled with FITC or Texas red, and thus could be ob-
served directly. Apoptotic cells were visualized by TUNEL staining
or by granulocyte-specific myeloperoxidase immunofluorescence
staining using FITC- or Texas red–conjugated secondary anti-
bodies. Nuclei were counterstained with DAPI or propidium io-
dide at 1 ng/ml in PBS-CM. For competition experiments, OS
and apoptotic cells were labeled with different fluorochromes.
Particle labeling with either fluorochrome yielded identical re-
sults. Unlabeled particles competed with fluorescence-labeled
particles for binding and phagocytosis by all cell types. For inhibi-
tion experiments, GRGDSP or GRADSP peptides (Calbiochem)
were used at 1 mg/ml. Effects of peptides and antibodies were
concentration dependent as established previously (26), and max-
imal effective concentrations of antibodies, 20–50 mg/ml, were
used throughout this study. Concentrations of pharmacological
reagents were as follows: calphostin C at 100 nM (light activated),
cytochalasin D (Cyt D) at 5–20 mM, Gö6976 at 10 nM, hyperi-
cin at 5 mM, and latrunculin B at 1 mM. PMA was routinely used
at 50 nM; 16–160 nM gave similar results. Cells were pretreated
for times indicated in the figure legends with activators or inhibi-
tors before challenge with OS or apoptotic granulocytes in the
continuous presence of reagent. Cell viability and morphology
remained unchanged, and none of the cell types initiated detect-
able apoptosis over the course of the experiments. Since experi-
ments were performed on confluent cells, the spreading effect of
PMA on macrophages was negligible.
Phagocytosis or binding of OS was quantified by fluorescence
scanning of fixed samples as described (26). Samples were scanned
with a STORM 860 Imager, at 950 V (blue or red fluorescence
setup; Molecular Dynamics). Areas representing the binding by
1–2 3 105 phagocytes were selected, and the fluorescent signals
were quantified with ImageQuant 1.2 (Molecular Dynamics).
Within one experiment, particle counts directly correlated with
particle binding. To compare particle binding of different cell
types, as RPE cells and macrophages, the fluorescence of propid-
ium iodide (nuclei, red) and the particle-derived FITC fluores-
cence were both measured in each field. The binding plus inter-
nalization index or the binding index (bound particles at early
times of phagocytic challenge) were calculated dividing particle
counts by nuclei counts, thereby normalizing for phagocyte
numbers. Quenching of fluorescence derived from externally
bound particles using trypan blue (26, 41) allowed determination
of the internalization index. Phagocytosis or binding of apoptotic
cells was quantified following the same procedure based on
TUNEL or myeloperoxidase immunostaining fluorescence emis-
sions; binding indices were determined dividing by nuclei counts
of control fields, so as not to count apoptotic nuclei. Microscopic
observation revealed that 75% of RPE-J cells and .90% of J774
cells had bound or phagocytosed an average of 5 6 1 OS after
2 h. Using the double fluorescence scanning method on the same
samples, this translated into a mean index combining binding plus
internalization of 7.6 6 0.9 for macrophages and 6.3 6 0.9 for
RPE. After 30 min, 75% of macrophages had bound multiple
OS; this translated to a mean binding index of 3.8 6 0.4. At this
time point, ,20% of particles had been internalized by macro-
phages, similar to the 2-h time point of RPE (26, 41).
Immunofluorescence Microscopy. Samples were fixed in ice-cold
methanol or 4% paraformaldehyde in PBS-CM and processed as
described previously (42). Samples were observed with a Nikon
fluorescence microscope E600. Digital images were acquired
with a back-illuminated cooled CCD camera (CCD1000 PB;
Princeton Instruments), translated using MetaMorph (Universal
Imaging), and recompiled in Adobe Photoshop® 4.0. Horizontal
(x–y) sections were acquired at 0.5-mm steps using a z motor
(Prior), and out of focus light was removed using MetaMorph.
Cell Fractionation. Integrin cytoskeletal association was as-
sayed by cell fractionation into detergent-soluble and insoluble
fractions according to previously described protocols (43). Con-
fluent cells in 6-cm dishes, preincubated with pharmacological
reagents or vehicle as before binding or phagocytosis assays, were
extracted in 800 ml 50 mM MES, 5 mM MgCl2, 3 mM EGTA,
0.5% Triton X-100, pH 6.4, for 40 s at room temperature (solu-
ble fraction). The remaining cellular material was completely sol-
ubilized in an equal volume of RIPA (50 mM Tris-HCl, pH 7.8,
150 mM NaCl, 2 mM CaCl2, 1 mM MgCl2, 0.1% SDS, 1% so-
dium desoxicholate, 1% Triton X-100) (insoluble fraction). Equal
volumes of soluble and insoluble fractions were compared by
7.5% SDS-PAGE and immunoblotting. For immunoprecipita-
tion of integrins from the different fractions, the soluble fraction
was harvested as described above, whereas the insoluble fraction
was obtained by scraping the remaining cellular material in an
equal volume of 50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 2
mM CaCl2, 1 mM MgCl2, 1% Triton X-100, 1% NP-40 supple-
mented with 2 mM each of aprotinin, leupeptin, pepstatin, io-
doacetamide, and PMSF, and 1 mM N-ethylmaleimide (IP lysis
buffer), vortexing for 30 min at 48C. This procedure completely
solubilized integrin proteins. Immunoprecipitations were per-
formed from this insoluble and the soluble fraction as follows.
Surface Protein and Immunoprecipitations, SDS-PAGE, and Im-
munoblotting. For metabolic labeling, confluent cells on plastic864 Phagocyte Regulation of Integrin avb5 for Apoptotic Cell Binding
dishes were starved for 90 min in cysteine, methionine-free
DMEM, and labeled with 0.1 mCi/ml 35S Express (NEN) for
12–14 h. Preincubation with pharmacological reagents or vehicle
as control was performed as before binding/phagocytosis assays.
To biotinylate surface proteins, cells were incubated with Sulfo-
NHS-LC biotin (Pierce Chemical Co.) at 0.5 mg/ml in PBS-
CM twice for 20 min on ice. Excess reactive biotin was
quenched in 50 mM NH4Cl in PBS-CM. Cells were lysed in IP
lysis buffer for 30 min. Protein concentration of supernatant ly-
sates was determined according to Bradford (44). Crude lysates
were analyzed by nonreducing 7.5% SDS-PAGE followed by
Western blot detection of integrins as published previously (45).
Streptavidin-agarose precipitation has been described in detail
elsewhere (46). Immunoprecipitates were formed incubating pre-
cleared lysate with 5 mg P1F6 IgG or nonimmune mouse IgG,
with 5 mg rabbit anti–mouse IgG, and with 5 mg protein
A–sepharose, each for 1 h at 48C. Samples were washed four
times in 50 mM Tris-HCl, pH 8.5, 0.5 M NaCl, 2 mM CaCl2, 1
mM MgCl2, 1 mg/ml egg albumin, 0.1% Triton X-100 eluted in
nonreducing or reducing SDS sample buffer, and analyzed on
10% SDS-PAGE followed by fluorography or blotting. Blots
were incubated with integrin antibodies, horseradish peroxidase–
conjugated streptavidin, or secondary antibodies, followed by
ECL (NEN) detection. X-ray films were scanned, and signals
were quantified using NIH Image 1.61.
Results
Macrophages and RPE Cells Bind, Nonpreferentially, OS and
Apoptotic Cells but Use Different Integrins for This Purpose.
Blood monocyte or bone marrow–derived macrophages
Figure 1. Macrophages take up OS, and
RPE cells recognize and phagocytose apop-
totic cells. (a) Phase-contrast and (b) merged
fluorescence image of rat bone marrow–
derived macrophage phagocytosing FITC-
labeled OS (green) 40 min after particle
challenge. Macrophage nuclei were stained
with propidium iodide (red). (c) Phase-con-
trast and (d) merged fluorescence image of
RPE-J cell after internalization of an apop-
totic granulocyte, 3 h after phagocytic chal-
lenge. Apoptotic DNA was stained with
TUNEL (green), nuclei with propidium io-
dide. (e and f) RPE-J monolayer challenged
for 2 h with equal numbers of HL-60 cells,
which had been induced to undergo apop-
tosis (f) or not (e). Samples were stained for
myeloperoxidase to detect HL-60 cells
(green) and counterstained with propidium
iodide. RPE-J cells take up exclusively cells
from the apoptotic population. Bound or
phagocytosed HL-60 cells were also positive
in TUNEL staining (data not shown). Non-
apoptotic and apoptotic HL-60 cells ex-
pressed identical amounts of myeloperoxi-
dase (data not shown). Scale bars, 10 mm.865 Finnemann and Rodriguez-Boulan
use avb3 integrin receptors to bind apoptotic cells before
phagocytosis (7), whereas RPE cells bind OS via avb5 in-
tegrins (25, 26). We initially tested the hypothesis that the
characteristic choice of different integrin receptors by mac-
rophages and RPE cells was determined by differences in
the bound particles. To this end, we exposed the phago-
cytes to the physiologic ligands of the other cell, i.e., mac-
rophages to OS and RPE cells to apoptotic cells (Fig. 1).
Rat bone marrow macrophages and the murine macrophage
cell line J774, which retains the avb3 integrin–dependent
apoptotic cell clearance mechanism of noninflammatory
monocyte macrophages (13), efficiently bound and phago-
cytosed OS (Fig. 1, a and b). Primary cultures of rat RPE,
and rat (RPE-J) and human (ARPE-19) RPE cell lines
identified and took up apoptotic granulocytes (and other
apoptotic cells; data not shown), but not their nonapop-
totic counterparts (Fig. 1, c–f). Most subsequent studies
were performed on J774 macrophages and RPE-J cells, but
were confirmed on rat bone marrow–derived macrophages
and primary rat RPE cultures.
Particle binding and phagocytosis proceeded with kinet-
ics that were characteristic for each cell type. Macrophages
bound and internalized OS with the same rapid and linear
kinetics with which they take up apoptotic cells (Fig. 2 a,
and data not shown). The early phase of RPE clearance of
OS is characterized by a lag phase following particle chal-
lenge after which OS binding occurs rapidly (26). RPE
cells bound apoptotic cells as slowly as OS (Fig. 2 a). After
2 h of phagocytic challenge, the sum of bound plus inter-
nalized OS was similar in macrophages and RPE cells (Fig.
2 a). However, at this time 78 6 9% of these OS in mac-
rophages had been internalized, compared with only 17 6
4% internalized OS in RPE cells. Phagocytosis of apoptotic
cells bound by RPE cells followed the same slow time
course as previously established for OS: we removed un-
bound apoptotic cells after 2 h and followed the fate of
Figure 2. Apoptotic cells and OS compete for binding to avb3
of macrophages and for binding to avb5 of RPE cells. (a) Time
course of combined OS binding plus internalization by rat bone
marrow–derived macrophages (x) and NRK-F49 fibroblasts (d)
compared with RPE-J cell combined binding plus internalization
of OS (.) and apoptotic cells (,). J774 binding and internaliza-
tion were indistinguishable from those of rat primary macro-
phages. (b) Integrin dependence and RGD peptide inhibition of
binding of OS (black bars) and apoptotic cells (white bars) by
RPE-J cells and by J774 macrophages. Mean OS binding indices
in the absence of apoptotic cells were 6.3 6 0.9 for RPE-J and
3.8 6 0.4 for J774, after 2 h or 30 min of particle challenge, re-
spectively. At these time points, particle phagocytosis accounted
for ,20% of total particle count. Mean apoptotic cell binding in-
dices in the absence of OS were 5.5 6 0.4 for RPE-J and 3.7 6
0.5 for J774, at the same time points. (c) Quantitative competition
of OS with apoptotic cells for phagocyte binding. RPE-J and J774
macrophages were challenged with different ratios of OS and apop-
totic cells, for 2 h or 30 min, respectively. Particles were labeled
with different fluorophores (FITC and Texas red) and quantified
by fluorescence scanning. 100% represents binding of each particle
in the absence of the other; for binding indices, see b. OS, black
bars; apoptotic cells, white bars. Results represent means 6 SEM
(n 5 5). When challenged with equal numbers of OS and apop-
totic cells, both phagocytes seem to prefer apoptotic cells. How-
ever, this may be attributed to the larger size of apoptotic cells
compared with OS (see Fig. 1).866 Phagocyte Regulation of Integrin avb5 for Apoptotic Cell Binding
bound cells. Over the next 3 h, 85% of bound apoptotic
cells were internalized by RPE cells (26; and data not
shown).
To specifically address particle binding, we chose to
study 30 min of particle challenge for macrophages and 2 h
for RPE cells, both of which corresponded primarily to the
recognition/binding phase of particle clearance (see above,
and Materials and Methods). Peptides containing the cog-
nate integrin-binding motif, RGD, reduced binding of
both particles by either phagocyte (Fig. 2 b). In contrast,
function-blocking b3 antibodies only inhibited particle
binding by macrophages while avb5 antibody P1F6 only
blocked RPE recognition (Fig. 2 b). OS and apoptotic cells
competed for binding by both macrophages and RPE cells
(Fig. 2 c). These experiments indicate that neither mac-
rophage nor RPE binding receptor systems discriminate
between ligands of both particles and that these systems in-
volve avb3 in macrophages and avb5 in RPE cells.
Binding of Apoptotic Cells and OS by avb5 Is Dormant in
Macrophages but May Be Activated by PKC. We tested three
hypotheses that might account for particle binding by dif-
ferent integrin binding receptors in macrophages and RPE
cells. Hypothesis 1 was that cell type–specific integrin pro-
tein expression determined receptor availability for particle
binding. However, Fig. 3 shows that selective integrin
expression was not involved, as both b3 and b5 were ex-
pressed at similar levels by J774 cells, rat bone marrow–
derived macrophages, and RPE-J cells. Immunoprecipita-
tion of avb5 from RPE and macrophage lysate using the
antibody P1F6, which recognizes only intact heterodimers,
and coimmunoprecipitation of b3 integrin with av inte-
grin confirmed the formation of avb3 (data not shown)
and avb5 receptors (see Fig. 8). We have shown previously
that the steady state distribution of b3 integrins is basolat-
eral in the RPE (26). Although this does not exclude a
temporary presence of avb3 at the apical phagocytic sur-
face, this spatial segregation may render it less available for
efficient apoptotic cell or OS binding by the RPE than
avb5, which localizes apically and cytoplasmically. In con-
trast, double immunofluorescence staining with antibodies
recognizing the b3 extracellular domain and with P1F6 an-
tibodies specific for the extracellular face of the avb5 re-
ceptor complex showed that in nonpermeabilized mac-
rophages, both antigens were localized in the same optical
sections of the plasma membrane of a given cell, even if
their distribution within the plane of the membrane dif-
fered. Like b3 integrins, avb5 receptors localized partially
to basal attachment sites of macrophages but were also
available at their free surface for binding to apoptotic cells
or OS.
Hypothesis 2, applicable to macrophages, was that their
preferred use of avb3 for apoptotic cell or OS binding
might be based on the faster early kinetics of this pathway
over avb5-mediated uptake (Fig. 2 a). To facilitate detec-
Figure 3. J774 and rat mac-
rophages express similar levels of
av, b3, and b5 integrin subunits
as rat RPE-J cells and rat NRK-
F49 fibroblasts. Proteins were
detected by comparative immu-
noblotting after SDS-PAGE of
50 mg each of detergent lysates
of RPE-J cells, J774 macro-
phages, primary rat monocytes
(Mono), and rat NRK-F49 fi-
broblasts. Tested rodent primary macrophages and cell lines expressed
levels of b5 integrin protein comparable to RPE cells, while an earlier
study did not detect b5 in human monocyte–derived macrophages (refer-
ence 29). This may be attributed to species differences, or to differences
in in vitro monocyte maturation conditions.
Figure 4. b3 integrin and avb5 integrin localize to attached and free
macrophage plasma membrane. b3 integrins but not avb5 integrin redis-
tribute to attachment sites in macrophages seeded on fibrinogen substrate.
Immunodetection of surface integrins was performed on unpermeabilized
cells with b3-specific or avb5 receptor–specific antibodies. Top and bot-
tom panels shown are en face views of the apical and the attached cell sur-
face, respectively. (a) b3 and avb5 integrin distribution in J774 macro-
phages attached to laminin-coated coverslips for 30 min. b3 and avb5 are
present on both surfaces, as demonstrated by the immunofluorescence
signals in horizontal optical sections at the levels of attached (a1 and a3)
and free (a2 and a4) cell surfaces. (b) Same staining as in a, of J774 mac-
rophages seeded on fibrinogen for 30 min, reveals specific relocalization
of b3 integrins to attachment sites. Compare a1 with b1, a2 with b2.
Scale bars, 10 mm.867 Finnemann and Rodriguez-Boulan
tion of a hidden avb5 particle binding activity, avb3 re-
ceptors were depleted from the free macrophage surface.
When compared with control cells plated on laminin
(which is not a substrate for either avb3 or avb5), a large
fraction of avb3 receptors was recruited to the attached
surface in macrophages plated on the specific avb3 sub-
strate fibrinogen (47; compare Fig. 4, a1 and a2, with Fig.
4, b1 and b2), resulting in a reduction in particle binding of
40% after 30 min of particle challenge (Fig. 5 a), and a 44%
decrease of combined binding and internalization even af-
ter 90 min (Fig. 5 b). avb5 receptor distribution remained
unchanged on fibrinogen, as judged from the similar ap-
pearance of avb5 immunofluorescence signals on both at-
tached and open cell surfaces on laminin and fibrinogen
(compare Fig. 4, a3 and a4, with Fig. 4, b3 and b4). How-
ever, the remaining binding at 30 min and the combined
binding plus internalization at 90 min were still reduced by
b3 but not by avb5 function-blocking antibodies (Fig. 5).
Incubation with b3 antibody in the presence of the peptide
inhibitor GRGDSP did not have an additive effect (but the
peptide alone reduced binding by z30%; data not shown,
and see Fig. 2 b), indicating that avb3 was the only RGD-
sensitive receptor, which mediates apoptotic cell or OS
recognition in this system. However, ligand binding by
leukocyte b2 integrins may not be inhibitable by RGD
peptides (48). At the 90-min time point, at least 65% of the
particles had been internalized (Fig. 5 b, black bars). Com-
paring total and internal particles of laminin- and fibrino-
gen-seeded macrophages, differences in internalized particles
were less pronounced than differences in surface-bound
particles (as deduced by subtracting internal from total par-
ticles), confirming that attachment to fibrinogen inhibited
particle binding but not internalization (Fig. 5 b, gray and
black bars). Similar results were obtained when cells were
plated on b3 integrin antibodies or on vitronectin, a sub-
strate for both avb3 and avb5 (Fig. 5). These experiments
indicate that avb5 integrin receptors are present in mac-
rophages but are not active in apoptotic cell or OS binding.
Hypothesis 3 was that integrin-mediated binding of apop-
totic cells or OS was subject to cell type–specific regula-
tion. Several earlier studies have reported that, unlike avb3
integrin, avb5 is sensitive to pharmacological modulation
by protein kinase C (PKC) (33, 49, 50). Here, we com-
pared the effects on macrophage and RPE particle binding
of generic PKC activation using phorbol esters (PMA), and
inhibition by calphostin C, Gö6976, and hypericin. Inhibi-
tors were used at concentrations near IC50 for PKC. PMA
treatment did not alter RPE particle binding; on the other
hand, calphostin C, Gö6976, and hypericin reduced bind-
ing by RPE cells (Fig. 6 a). Significant inhibition (by 54%)
by calphostin C required a preincubation of 3 h. It is possi-
ble that RPE cells take up calphostin C more slowly than
other cultured cells or maintain lower cytoplasmic concen-
trations of this inhibitor. Hypericin and Gö6976 signifi-
cantly reduced particle binding after as little as 30 min of
preincubation by 39 and 22%, respectively, but both were
also more effective after 3 h of preincubation (69 and 81%
reduction). These experiments indicate that the apoptotic
cell or OS binding activity of resting confluent RPE cells is
drastically reduced by pharmacological inhibition of PKC.
A strikingly different scenario was observed in the case of
macrophages. PKC inhibition by calphostin C, Gö6976, or
hypericin did not alter particle binding, regardless of prein-
cubation time. On the other hand, stimulation of PKC by
incubation with PMA increased particle attachment by
45%. This enhanced binding activity was sensitive to
RGD-containing peptides, to b3 antibodies, and, impor-
tantly, to avb5 antibody Fab fragments (Fig. 6 b). Thus,
PMA treatment activated avb5-mediated particle binding
that was dormant in untreated macrophages. The effect of
the PMA treatment directly involved PKC, since it was
abolished by preincubation of cells with calphostin C for 20
Figure 5. Effects of attachment on different
extracellular substrates or b3-specific antibod-
ies on J774 macrophage apoptotic cell or OS
binding and internalization. J774 macrophages
were seeded on coated coverslips in serum-free
medium for 30 min. Particles were added for 30
min (a) or 90 min (b) in the presence or absence
of inhibitory antibodies or peptides. White (a)
and gray (b) bars, hatched or not, represent mean
binding plus internalization indices 6 SEM (n 5
6). Black bars represent mean internalization in-
dices 6 SEM (n 5 3). Note that cells seeded for
30 min before particle challenge, as studied in
this experiment, bound fewer particles than cells
which had attached overnight (see Fig. 2).
Results represent data from OS challenges.
Identical results were obtained challenging with
apoptotic cells. Cell adhesion or morphology
did not notably change due to attachment to
the b3 antibody or to different substrates (LN,
laminin; Fb, fibrinogen; VN, vitronectin). At-
tachment to avb5 or b1 antibody had no effect
on particle binding (data not shown).868 Phagocyte Regulation of Integrin avb5 for Apoptotic Cell Binding
min before PMA and particle challenge. To confirm the
PKC dependence of avb5-mediated apoptotic cell or OS
binding in a different cell context, we carried out similar
experiments in NRK-F49 fibroblasts. When challenged
with OS for 2 h, these cells bind (but do not internalize)
few OS, equivalent to one fifth of the number bound by
RPE over the same period (Fig. 2 a), although they express
comparable levels of av, b3, and b5 integrins (Fig. 3). In-
cubation with integrin antibodies had no effect on the basal
NRK-F49 particle binding of apoptotic cells or OS (data
not shown). However, addition of PMA stimulated particle
binding by NRK-F49 fibroblasts by 250% to a binding in-
dex of 3.4 6 0.5, which is an increase to approximately
half-maximal binding capacity of professional phagocytes.
Strikingly, this induced binding activity was completely
sensitive to RGD peptides, was blocked specifically by
avb5 antibodies, and was not sensitive to b3 antibodies
(Fig. 6 c). Over the 2-h time period studied, NRK-F49 fi-
broblasts retained particles at the surface and did not in-
ternalize them, regardless of pharmacological stimulation.
These experiments demonstrate that inhibition and activa-
tion of PKC regulate the function of avb5 integrin as
binding receptor for apoptotic cells or OS.
To determine if the stimulated avb5 integrin–mediated
particle binding in macrophages exhibited typical features
of OS binding by RPE cells, we compared the temperature
sensitivity and kinetics of particle binding and internaliza-
tion by J774 cells, in the presence or absence of PMA. To-
tal (bound plus internalized) and internalized particles were
measured to calculate binding and internalization indices
plotted in Fig. 7. Onset of binding of apoptotic cells or OS
to control and PMA-stimulated cells occurred with the
same rapid kinetics typical of macrophages (Fig. 7 a, solid
lines). When challenged with particles for 30 min or
longer, both control and PMA-stimulated cells increasingly
internalized bound material (Fig. 7 a, dotted lines), result-
ing in a decrease in particles detected bound to the cell sur-
face. J774 cells, which were equilibrated to 188C before
particle challenge, also bound both particles with the same
fast kinetics regardless of whether they had been preincu-
bated with PMA or with solvent alone, albeit slightly de-
layed regarding the 378C time course (Fig. 7 b, solid lines).
Under these conditions, ,10% of total particles were inter-
nalized regardless of PMA treatment and time of incuba-
tion (Fig. 7 b, dotted lines). Finally, incubation at 148C or
on ice during particle challenge abolished particle binding
with or without PMA treatment (Fig. 7, c and d), while al-
lowing normal binding of complement-opsonized zymosan
via macrophage aMb2, sensitive to aM-blocking antibody
5C6 (data not shown). These experiments demonstrate that
apoptotic cell or OS binding by macrophages via avb3 or
avb3 plus avb5 integrin shows the same temperature re-
quirement as particle binding via avb5 to RPE cells. On
the other hand, PMA-stimulated macrophages, which pos-
sess an activated avb5 integrin, bind apoptotic cells or OS
with the same rapid kinetics as control macrophages, which
do not use avb5, indicating that RPE particle binding does
not occur slowly due to an intrinsic property of avb5.
Figure 6. avb5 apoptotic cell or OS binding activity requires PKC
stimulation. Endogenous PKC signaling preactivates avb5 binding by
RPE cells, and stimulation of PKC induces a novel avb5-dependent
binding mechanism in macrophages and fibroblasts. Cal C, calphostin C.
100% binding represents binding of DMSO controls for each phagocyte.
Results are expressed as means 6 SEM, of six independent experiments
performed in duplicate. Using the Student’s t test, P , 0.001 for all con-
ditions discussed as significant in the text. (a) Effects of PKC activators
and inhibitors on RPE-J particle binding. Longer preincubation time in-
creased the effects of all PKC inhibitors used, suggesting that immediately
before particle addition, RPE avb5 is already activated. Mean binding in-
dex of controls (100%) after 2 h of particle challenge was 5.39 6 0.9 re-
gardless of preincubation time. (b) Effect of PKC activators and inhibitors
on macrophage particle binding. J774 or rat primary macrophages were
preincubated for 30 min or 3 h in growth medium with pharmacological
reagents or solvent, before OS challenge for 30 min. Similar results were
obtained incubating with apoptotic cells, which competed with OS for
binding to PMA-activated macrophages (data not shown). Binding index
of controls (100%) was 4.2 6 0.7. (c) Activation of avb5-mediated parti-
cle binding in NRK-F49 fibroblasts induced by PMA treatment. Cells
were preincubated with reagents for 30 min before challenge with OS for
2 h, at which time point numbers of internalized apoptotic cells or OS
were insignificant. Mean binding index of control fibroblasts was 1.36 6
0.2, and of PMA-treated cells was 3.4 6 0.5.869 Finnemann and Rodriguez-Boulan
PKC-activated avb5 Is Linked to the Actin Cytoskeleton.
To gain insight into the mechanism of activation of avb5-
mediated binding of apoptotic cells or OS by PKC, we
searched for biochemical changes associated with PKC ac-
tivation. Pharmacological activation or inhibition of PKC
did not influence avb5 receptor levels in either cell type
(Fig. 8 a, compare lane 2 with lane 3, and lane 5 with lane
6) or their steady state expression levels at the cell surface,
as revealed by surface biotinylation, avb5 immunoprecipi-
tation, and streptavidin blot (Fig. 8 b, lanes 1–6) or enrich-
ment of plasma membrane fractions and b5 immunoblot
(Fig. 8 b, lanes 7–12). Incomplete extraction of plasma
membrane proteins with 0.5% Triton X-100 in a buffer
that preserves the cortical cytoskeleton serves to distinguish
integrin receptors, which are stabilized by actin cytoskeletal
elements (43, 51). PKC inhibition in RPE and PKC acti-
vation in macrophages correlated with decreased and in-
creased b5 resistance to nonionic detergent, respectively, as
shown in Fig. 9, a and b, suggesting a regulation of b5 as-
sociation with actin cytoskeletal elements. b5 was 65% in-
soluble in control RPE, 58% insoluble in PMA-treated
RPE, but only 33% insoluble in RPE treated with PKC in-
hibitor Gö6976. In contrast, b5 was mostly soluble in con-
trol macrophages (5% insoluble) but became 78% insoluble
after PMA incubation. This effect was greatly inhibited in
the presence of Gö6976 (23% insoluble). This effect was
specific for b5, as b3 solubility was unaffected by PKC ac-
tivation/inhibition (Fig. 9, a and b, lower lanes). b3 inte-
grin was 30% insoluble in RPE and 40% insoluble in J774
cells, regardless of treatment. Pretreatment of RPE or mac-
rophages with the actin microfilament disrupting drug, Cyt
D, rendered b3 and b5 completely soluble in RPE and
macrophages, confirming that integrin resistance to non-
ionic detergent extraction in our biochemical analysis re-
flected their association with actin microfilaments (Fig. 9, a
and b, lanes 7 and 8). As expected, PMA treatment did not
induce integrin insolubility in cells in which actin microfil-
aments had been disrupted by Cyt D (Fig. 9, a and b, lanes
9 and 10). We further determined the detergent solubility
of intact avb5 receptors (Fig. 9 c). Strikingly, the effect of
PKC activation or inhibition on avb5 heterodimer solubil-
ity was most pronounced: 90% of avb5 in RPE cells was
insoluble but became mostly solubilized (26% insoluble)
upon incubation with the PKC inhibitor Gö6976 (Fig. 9 c,
lanes 1–6). In control macrophages, the entire avb5 recep-
tor pool was present in the soluble fraction (Fig. 9 c, lanes 8
and 10). In contrast, PMA-treated macrophages exhibited
62% insoluble avb5 (Fig. 9 c, lanes 11 and 12). Attempts to
visualize the change in receptor solubility by indirect im-
munofluorescence staining of avb5 or b5 in cells fixed be-
fore or after a short pulse of nonionic detergent failed, as,
unfortunately, detergent pretreatment abolished all im-
munoreactivity. Loss of immunoreactivity after detergent
treatment was independent of cell type or pharmacological
treatment, suggesting that antibody–antigen binding did
not tolerate detergent treatment followed by paraformalde-
hyde fixation. Nonetheless, the biochemical changes ob-
served clearly demonstrate that avb5 function as particle
binding receptor correlates with its increased resistance to
nonionic detergent extraction, which was reversibly regu-
lated by PKC signaling.
To directly test the possibility that an intact actin cyto-
skeleton might be required for avb5-mediated particle
binding, we challenged J774 macrophages with OS in the
Figure 7. Temperature sensitivity of apop-
totic cell or OS binding and internalization
by macrophages. Particle binding by mac-
rophages, which use both avb3 and avb5,
retains the fast macrophage binding kinetics
and onset of binding. J774 cells were chal-
lenged with apoptotic cells or OS after 20
min preincubation with PMA (.) or sol-
vent alone (d) and preequilibration to dif-
ferent temperatures for 20 min. To establish
binding indices for all temperatures, inter-
nalized particle counts were subtracted from
counts representing bound plus internalized
particles. Binding indices are plotted in solid
lines for four temperatures: (a) incubation at
378C, (b) 188C, (c) 148C, and on ice (at
08C) (d). At both 378C and 188C, binding
by PMA-treated cells exceeded that by con-
trol cells by approximately the same margin
at all times. Thus, the onset of avb5-medi-
ated binding by macrophages was fast and
there was no lag phase as characteristic for
avb5 binding by RPE. Reequilibration of
cells to permissive temperatures after 60 min
on ice restored their binding activity, and
led to increased binding in the presence of
PMA (data not shown), excluding nonspecific cell damage. Internalization indices are plotted in dotted lines. Internalization occurred regardless of treat-
ment at 378C (a). Cells at 188C bound but did not internalize particles (b), but internalized prebound particles within 45 min after being shifted to 378C
(data not shown). Complement-opsonized zymosan binding occurred efficiently at all temperatures (data not shown). Values shown represent means 6
SEM (n 5 3) of results obtained with OS. Identical results were obtained challenging macrophages with apoptotic cells.870 Phagocyte Regulation of Integrin avb5 for Apoptotic Cell Binding
presence or absence of PMA and Cyt D. Fig. 10 shows par-
ticle binding determined at 188C to minimize phagocytosis
of bound particles. OS bound efficiently to control mac-
rophages even in the presence of Cyt D (Fig. 10), in both
cases in an b3 integrin–sensitive, avb5-independent manner
(average b3 antibody inhibition 59% in control cells, 42%
in Cyt D–treated cells). Increased OS binding in the pres-
ence of PMA exhibited the dual b3- and avb5-dependent
mechanism (51% inhibited by b3 antibody, 39% inhibited
by avb5 antibody), and blocking of both integrins with a
combination of antibodies resulted in maximal inhibition
of OS binding (75%). Strikingly, the addition of Cyt D de-
creased OS binding to PMA-treated cells by 40%, abolish-
ing the increase induced by PMA. Addition of avb5-
inhibiting antibody to these cells had no effect, whereas OS
binding remained sensitive to b3-inhibiting antibodies
(52% inhibition). Similar effects on PMA-induced particle
Figure 8. PKC activation or inhibition does not alter levels or plasma
membrane localization of avb5 receptors. RPE-J cells were pretreated
with solvent (2) or PMA for 30 min (P) or with Gö6976 for 3 h (G) be-
fore lysis. J774 cells were pretreated with solvent (2), PMA (P), or
Gö6976 for 30 min (G), and lysed. (a) avb5 heterodimer levels. Immu-
noprecipitates from total IP lysate with nonimmune mouse IgG (lanes 1,
4, 7, and 9), or with avb5 antibody P1F6 (other lanes). Lanes 1–6 are flu-
orographs after immunoprecipitation from radioactively labeled cells and
nonreducing SDS-PAGE. Lanes 7–10 are immunoblots after immuno-
precipitation from unlabeled RPE-J and J774 lysates detected with b5 an-
tibody B5-IVF2 after reducing SDS-PAGE. P1F6 antibody precipitated
avb5 heterodimers from both metabolically labeled RPE-J and J774 cells,
and quantification revealed z25% higher levels in the RPE (compare
lane 2 with lane 5; relative intensities RPE 1.0/J774 0.78). Immunoblot-
ting of b5 with antibody P1F6 gave similar quantification results and fur-
ther confirmed the specificity of P1F6 for rodent avb5. Pharmacological
activation or inhibition of PKC did not influence avb5 receptor levels in
either cell type, and intensity differences were not significant. (b) Cell
surface localization of avb5. Cells were pretreated and surface biotiny-
lated before lysis. In lanes 1–6, immune complexes precipitated with
P1F6 from biotinylated lysates were probed with streptavidin-peroxidase/
ECL after reducing SDS-PAGE and blotting. Similar steady state levels of
surface avb5 receptors were detected in RPE-J or J774, regardless of
PKC inhibition or activation. Note that, under reducing conditions, the
av subunit appears at a lower molecular mass than under nonreducing
conditions (z110 kD reduced, z140 kD nonreduced). Other bands, pos-
sibly coprecipitates, were not identified. Lanes 7–12 show surface protein
fractions enriched by streptavidin-agarose precipitation separated by re-
ducing SDS-PAGE. Immunodetection with b5 antibody B5-IVF2 con-
firmed equal amounts of b5 protein at plasma membranes of RPE-J cells,
regardless of PKC status (lanes 7–9). The same was true for J774 cells
(lanes 10–12). One of three representative experiments is shown for each
method. In both types of experiments, minor variations did not corre-
spond to PKC modulation and were insignificant.
Figure 9. PKC activation or inhibition affects the cytoskeletal stabiliza-
tion of avb5 integrin receptors in RPE and in macrophages. (a and b) b5
but not b3 resistance to nonionic detergent extraction correlated with
PKC activation in RPE and macrophages. Pretreatment conditions were
as in Fig. 8. G1P represents treatment with Gö6976 for 15 min, followed
by the addition of PMA to this inhibitor medium for 30 min. After pre-
treatment, cells were separated in detergent-soluble and insoluble frac-
tions as described in Materials and Methods. Protein concentrations in the
fractions revealed that 35% total cellular protein was present in the soluble
fraction, and 65% in the insoluble fraction. This distribution was the same
comparing RPE and macrophages and did not change after treatment
with PKC activators or inhibitors. Integrin distribution in subcellular
fractions were compared by Western blotting with b5 polyclonal anti-
body (upper lanes) or b3 antibody 26 (lower lanes) after nonreducing
SDS-PAGE. Lanes with odd numbers are soluble fractions (labeled s), and
lanes with even numbers are the corresponding insoluble fractions (la-
beled i), of cell types and treatment as indicated (see legend to Fig. 8). Ac-
tin microfilament disruption with 10 mM Cyt D completely solubilized
b3 and b5 (a and b, lanes 7 and 8) and prevented PMA-induced recruit-
ment of b5 into insoluble fractions (a and b, lanes 9 and 10). Shown here
is one representative experiment out of a total of five experiments. Corre-
sponding soluble and insoluble fractions were separated in duplicate on
the same gels and blotted for b5 or b3. The appearance of unidentified
secondary bands in some b5 blots was variable and did not correlate with
pharmacological treatment. (c) PKC activation or inhibition regulated ex-
tractability of avb5 heterodimeric receptors. Metabolically labeled cells
were pretreated and separated into soluble (lanes 1, 2, 5, 7, 8, and 11, la-
beled s) and insoluble fractions (lanes 3, 4, 6, 9, 10, and 12, labeled i).
From each fraction, immunoprecipitates with nonimmune mouse IgG
(lanes 1, 3, 7, and 9) or P1F6 antibody (all other lanes) were analyzed by
nonreducing SDS-PAGE and fluorography. Note that J774 immunopre-
cipitates with P1F6 after separation of cells into soluble and insoluble frac-
tions exhibited lower backgrounds than immunoprecipitates from total
cell lysates (see Fig. 8 a, lanes 5 and 6), possibly due to the dilution of pro-
teins that bound nonspecifically to P1F6 immune complexes. Quantifica-
tion values given in the text represent means of four experiments, of
which one representative experiment is shown.871 Finnemann and Rodriguez-Boulan
binding only were observed when 1 mM latrunculin B, a
different actin-disruptive drug, was substituted for Cyt D
(data not shown). When we tested RPE-J particle binding
in the presence of 5–20 mM Cyt D, we also found their
binding activity reduced. However, the morphology of the
epithelium was dramatically altered after 2 h of actin dis-
ruption. These experiments demonstrate that, in macro-
phages and RPE-J cells, binding of apoptotic cells or OS to
avb5 integrin receptors but not to avb3 required intact
actin microfilaments.
Discussion
The experiments reported here demonstrate that nonin-
flammatory phagocytosis of apoptotic cells or OS can pro-
ceed along routes gated by different integrin-binding re-
ceptors, avb3 and avb5. Several important aspects of the
particle recognition functions of these integrins were un-
raveled.
Recognition Mechanisms of RPE Cells and Monocyte Mac-
rophages Do Not Distinguish between Surface Signals of Photore-
ceptor Outer Segments and Signals Exposed during Apoptosis.
Although RPE cells lack inflammatory phagocytic mecha-
nisms mediated in immune cells by Fc receptors, comple-
ment receptors, and glycan receptors, they possess a highly
efficient clearance pathway for OS. The RPE phagocytic
mechanism for OS and apoptotic cells has a capacity similar
to the monocyte macrophage phagocytic mechanism. Our
results confirm and extend earlier reports that described the
extraordinary specificity of the RPE recognition machinery
towards OS (20) and of the machinery used by noninflam-
matory macrophages for apoptotic over normal cells (4).
OS and apoptotic cells quantitatively compete for both
monocyte macrophage and RPE binding, demonstrating
that the binding receptors used by either cell type to ini-
tiate phagocytosis of these types of particles do not discrim-
inate between them. They also suggest that at least some of
the local surface changes elicited by the daily photoreceptor
outer segment renewal program are functionally equivalent
to the recognition signals exposed during apoptosis.
RPE Cells Use avb5 Integrin, Whereas Macrophages Use avb3
Integrin to Bind Both OS and Apoptotic Cells. Surprisingly, rat
primary and murine J774 macrophages used avb3 integrin
to bind OS, even though they expressed abundant avb5
integrin at the cell surface. The partial reduction in particle
binding observed when using avb3 inhibitory antibodies
and RGD peptides on macrophages confirms earlier reports
that they also use nonintegrin binding receptors for apop-
totic cells or OS, presumably in parallel mechanisms (for a
review, see reference 11). In contrast, RPE cells likely use
avb5 integrin as primary binding receptor for OS, as
avb5-inhibiting antibodies abolish 85% of particle binding.
RPE cells bound apoptotic cells as efficiently as OS via an
avb5-dependent pathway, even though they express equal
levels of b3 integrins as macrophages. Since b3 integrins in
RPE cells are polarized at the basolateral surface of the
RPE, their availability for particle binding may be limited.
Although we expect this hypothesis to be difficult to test
experimentally in epithelial cells, macrophages do not share
similar permeability barriers between plasma membrane
domains. Indeed, on appropriate immobilized substrates or
specific antibodies, b3 integrins were efficiently trapped at
macrophage attachment sites, leaving avb5 receptors ex-
posed at the particle contact surface of the phagocytes. In
spite of their favorable exposure, avb5 receptors failed to
mediate apoptotic cell or OS binding. These experiments
clearly demonstrate that neither the ligand (OS versus
apoptotic cells), the exclusive expression of a given integrin
receptor (avb3 versus avb5), nor its localization at the site
of particle contact is sufficient to generate the characteristic
receptor selectivity of RPE and macrophage particle recog-
nition.
The Selection of a Particular Integrin Receptor by a Given
Phagocyte Is Determined by the Activation of Specific Signaling
Pathways. Our results show that specific cellular context
determines which integrin receptor, avb3 or avb5, will be
activated for recognition and binding of OS and apoptotic
cells. Pharmacological studies revealed that the PKC signal-
ing pathway plays a key role in the activation of avb5 for
particle binding. Interestingly, RPE cells possess a maxi-
mally activated avb5 integrin–gated binding mechanism
Figure 10. avb5 integrin, but not avb3 integrin, requires actin mi-
crofilaments for apoptotic cell or OS binding. J774 macrophages were
preincubated with or without 10 mM Cyt D for 5 min, then PMA or sol-
vent was added for an additional 25 min. Cells were equilibrated to 188C
for 20 min and challenged with FITC-OS or apoptotic cells for 45 min.
At this time point, 188C binding was similar in amount to binding at
378C (see Fig. 7). Binding by cells treated with DMSO or PMA alone re-
produced the integrin inhibition pattern established for 30-min challenge
at 378C (see Fig. 6 b). Both integrins bound particles independently, as
dual inhibition had an additive effect on particle binding by PMA-treated
macrophages (cross-hatched bars). Cyt D reduced the particle binding in-
dex of PMA-activated samples to that of vehicle controls and abolished its
sensitivity to avb5 inhibition. Binding indices are means 6 SEM (n 5 3)
of results obtained with OS. Similar results were obtained challenging
macrophages with apoptotic cells.872 Phagocyte Regulation of Integrin avb5 for Apoptotic Cell Binding
that can be blocked by PKC inhibitors but cannot be en-
hanced by PKC stimulators. In contrast, monocyte mac-
rophages constitutively express a functionally equivalent
binding mechanism insensitive to PKC, in which avb3
plays an important role, but activate a dormant avb5 bind-
ing mechanism upon PKC stimulation that acts in parallel
with their avb3 pathway. Although there is no evidence to
date supporting a functional role for the novel avb5-medi-
ated particle recognition mechanism in phagocytosis by
monocyte macrophages, it is likely that this route may be
important in vivo. Indeed, an active avb5-dependent
phagocytic recognition mechanism for apoptotic cells was
recently described in immature dendritic cells (29), and our
results predict that PKC signaling may also be involved in
the regulation of avb5 binding activity in these cells. Fu-
ture studies should address the molecular mechanisms un-
derlying avb5 integrin activation by cellular inside-out sig-
naling mechanisms involving PKC (for a recent review, see
reference 52). It is equally important to understand the un-
availability of the abundant avb3 integrin receptors in the
RPE, which, as mentioned above, may be related to their
subcellular distribution, and the avb3 activation in mac-
rophages.
Temperature Sensitivity (188C) May Be an Intrinsic Property
of Recognition Receptors for Apoptotic Cells and OS, Whereas
the Kinetics and the Restoration of av Integrin–mediated Particle
Binding Are Determined by Cellular Context. Particle bind-
ing involving both avb3 and avb5 integrins share a re-
quirement of temperatures of at least 188C, which may be a
characteristic property of receptor mechanisms recognizing
apoptotic cells and OS. Importantly, our results show that
the activation of avb5-mediated particle recognition in
macrophages by PKC did not result in slower binding or a
lag phase after particle challenge, as would have been ex-
pected from the very slow kinetics of this process in RPE
cells. Furthermore, RPE cells retain their avb5 integrin–
dependent activity even after successive phagocytic chal-
lenges in vivo, and in vitro (Finnemann, S.C., unpublished
data). In contrast, macrophages lose their avb3 integrin–
dependent phagocytic recognition mechanism upon an ini-
tial particle challenge (2). Thus, RPE cells are permanent
noninflammatory phagocytes whose clearance mechanism
exhibits unique binding characteristics that cannot solely be
attributed to intrinsic properties of their primary recogni-
tion receptor, avb5 integrin.
PKC Activation or Inhibition Controls avb5 Integrin Func-
tion as Binding Receptor for Apoptotic Cells or OS by Regulating
Its Interaction with Cytoskeletal Elements: avb5 but Not avb3
Integrin–mediated Particle Binding Requires Intact Actin Microfil-
aments. Our findings agree well with earlier investigations
which demonstrated that avb5 but not avb3 integrin
function is sensitive to modulation by PKC signaling (33,
49, 50, 53). However, this is the first report to demonstrate
a specific effect of PKC on the association of avb5 itself
with the actin cytoskeleton. Our biochemical assays did not
determine whether PKC induced a direct or indirect asso-
ciation of avb5 with actin. Lewis et al. (50) have shown a
correlation between PMA activation of avb5 and a redis-
tribution or activation of several cytoskeleton-associated
molecules, e.g., a-actinin, tensin, and vinculin. These ac-
tin-associated proteins may mediate both mechanical as
well as signaling roles of integrin receptors. Cytoskeleton-
associated proteins and their roles in apoptotic cell or OS
binding and subsequent noninflammatory phagocytosis
have yet to be studied in detail. Before inflammatory
phagocytosis, particle binding to surface Fc receptors or
aMb2 integrins appears to be independent of the integrity
of the actin cytoskeleton (54, 55). The hypothesis that
binding of the same particle to a different integrin binding
receptor, in response to phagocyte- rather than ligand-
specified signals, induces different outside-in signaling ef-
fects, which ultimately determines properties of later phases
of phagocytic clearance, is intriguing and will be the sub-
ject of further studies. The unique susceptibility of RPE
phagocytes to genetic manipulation by viral or plasmid ex-
pression vectors in vitro and in vivo (42, 56) will certainly
be helpful in future studies designed to characterize the
roles of specific actin binding and regulatory proteins in
apoptotic cell or OS binding and phagocytosis.
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